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Abstract
Ras GTPases cycle between active GTP-bound and inactive GDP-bound forms to regulate a
multitude of cellular processes, including cell growth, differentiation, and apoptosis. The
activation state of Ras is regulated by protein modulatory agents that accelerate the slow intrinsic
rates of GDP dissociation and GTP hydrolysis. Similar to the action of guanine-nucleotide
exchange factors, the rate of GDP dissociation can be greatly enhanced by the reaction of Ras with
small-molecule redox agents, such as nitrogen dioxide, which can promote Ras activation.
Nitrogen dioxide is an auto-oxidation product of nitric oxide and can react with an accessible
cysteine of Ras to cause oxidation of the bound guanine nucleotide to facilitate Ras guanine
nucleotide dissociation. Glutathione has also been reported to modify Ras and alter its activity. To
elucidate the mechanism by which glutathione alters Ras guanine nucleotide binding properties,
we performed NMR and biochemical analyses of glutathiolated Ras. We determined that treatment
of H-Ras, lacking the non-conserved hypervariable region, with oxidized glutathione results in
glutathiolation specifically at cysteine 118. However, glutathiolation does not alter Ras structure
or biochemical properties. Rather, changes in guanine nucleotide binding properties and Ras
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activity occur upon exposure of Ras to free radicals, presumably through the generation of a
cysteine 118 thiyl radical. Interestingly, Ras glutathiolation protects Ras from further free radical-
mediated activation events. Therefore, glutathiolation does not affect Ras activity unless Ras is
modified by glutathione through a radical-mediated mechanism. 1
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Ras GTPases; glutathione; oxidation; reactive oxygen and nitrogen species; oxidative cysteine
modifications
Introduction
Ras proteins belong to a large superfamily of GTPases that bind to GDP and GTP with high
specificity and affinity. They function as molecular switches that cycle between the inactive
GDP-bound and active GTP-bound forms. Once activated, Ras GTPases interact with a
variety of effectors to activate signaling pathways that regulate gene expression, cell growth
and differentiation, and programmed cell death [1-3]. The structural differences between the
GDP- and GTP-bound states of Ras are primarily localized within two regions, Switch I
(residues 30-37) and Switch II (residues 60-76) [4]. The intrinsic rates of GDP exchange and
GTP hydrolysis are too slow to respond to cell signaling events [5], and consequently,
protein factors associate with Ras and accelerate these rates in a regulated manner. Guanine
nucleotide exchange factors (GEFs) accelerate exchange of bound GDP for GTP, which
leads to Ras activation [6], whereas GTPase activating proteins (GAPs) inactivate the
GTPase by facilitating GTP hydrolysis [7, 8]. Ras is considered the most prevalent oncogene
in human cancer, and oncogenic mutations have been identified in approximately 30% of
human tumors [9, 10]. Oncogenic Ras mutations render Ras constitutively active by
impeding down regulation by GAPs [11].
In addition to GEFs, reactive oxygen and nitrogen species (ROS; RNS) have been shown to
enhance guanine nucleotide exchange and activate Ras [12]. Two of the most common
oxidative modifications identified for Ras in vivo are nitrosation and glutathiolation [13].
Specifically, nitrogen dioxide (•NO2) has been shown to induce Ras guanine nucleotide
dissociation by causing guanine base oxidation through reaction with cysteine 118 (Cys118)
[14]. As the GTP:GDP ratio in cells is approximately 10:1, oxidation-mediated GDP
dissociation can promote GTP loading of Ras, analogous to the action of GEFs [15]. While
the reaction of nitric oxide and its auto-oxidation product, •NO2, with Ras have been
characterized, it is less clear how other thiol modifications (i.e., glutathiolation) affect Ras
activity. As numerous studies have described activity modulation of Ras in the presence of
ROS and RNS, we refer the reader to two recent reviews that detail the redox regulation of
Ras and Ras-related GTPases [12, 16].
Ras contains a solvent accessible cysteine (X) in the nucleotide-binding NKXD motif. While
this cysteine is conserved in H-, K- and N-Ras, it does not form interactions with other
residues in Ras or the guanine nucleotide ligand and is poorly conserved in the Ras
superfamily. We have previously postulated that Cys118 is conserved in N-, K-, and H-Ras
due to its role in the redox regulation of Ras [15]. In fact, Cys118 has been shown to react in
vitro and in vivo with a variety of thiol oxidizing agents, including oxidized glutathione,
superoxide, and nitric oxide-derived oxidants [13]. We have previously characterized a
redox inactive variant of Ras (RasC118S) that retains similar structure and biochemical
properties as RasWT [17, 18]. RasC118S has been used in numerous in vitro and cell-based
studies to discriminate between direct and indirect mechanisms of Ras activity modulation
by Cys118-mediated oxidation [reviewed in 12, 13]. As we have previously shown that S-
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nitrosation of Ras (RasSNO) at Cys118 does not significantly alter Ras structure, biochemical
properties, or binding to the Ras-binding domain of Raf-1 [19], we postulated that NO
modulates Ras activity by formation of a thiyl-radical intermediate, which leads to oxidation
of the bound guanine base, likely through electron transfer. In support of this premise, we
have previously shown that treatment of Ras with •NO2 promotes the oxidation and release
of the bound guanine nucleotide [14]. In addition, we have recently detected the presence of
a Ras-thiyl radical upon treatment of RasWT with NO using the immuno-spin trapping (IST)
reagent 5,5-dimethyl-1-pyrroline N-oxide (DMPO); no radical was detected when RasC118S
was used [20]. Thus, we propose that Ras thiyl-radical formation, as opposed to S-
nitrosation, induces oxidation and release of the guanine nucleotide base, which can lead to
Ras activation.
In addition to S-nitrosation, several studies have observed that Ras can undergo
glutathiolation. This oxidative modification was suggested to increase nucleotide exchange
and promote Ras activation [21-27]. In particular, detection of Ras glutathiolation coincident
with Ras activation was observed after exposure of bovine aortic endothelial cells (BAECs)
to peroxynitrite [21, 27], addition of angiotensin II to vascular smooth muscle cells
(VSMCs) [26, 28], and exposure of H2O2 to rat ventricular myocytes [23, 25]. However,
addition of these agents to cultured cells can produce redox agents capable of protein thiyl
radical formation. For example, peroxynitrite can react with cellular CO2 to produce CO3 •−
and •NO2 radicals, and under acidic conditions (peroxynitrite pKa is ~6.6), peroxynitrite can
decompose to hydroxyl radical and •NO2 [29]. Furthermore, peroxynitrite and angiotensin II
can dysregulate several kinase pathways, including the PI3K/Akt pathway, and increase the
production of cellular NO by activation of endothelial nitric oxide synthase (eNOS) [30, 31].
The NO produced by eNOS can auto-oxidize to produce •NO2, which is a powerful oxidant
capable of thiyl radical formation. Consistent with observations of Liaudet et al. and Ushio-
Fukai et al., the PI3K/Akt pathway was activated after exposure of BAECs to peroxynitrite
[21]. Intriguingly, in a pancreatic cancer cell line and a severe combined immunodeficiency/
Beige mouse model, activation of PI3K has been shown to activate Ras via eNOS
stimulation through a redox-mediated mechanism dependent on Cys118 [32]. Furthermore,
peroxynitrite and angiotensin II signaling both activate NADPH oxidase, which can produce
waves of reactive oxygen species long after peroxynitrite decomposition [33]. Lastly, H2O2
can produce free radicals through the Fenton reaction by reacting with transition metals
present in cells. Thus, based on our previous characterization of nitrosated Ras [19], we
postulate that Ras activation observed by Clavreul et al. [21, 27] and Adachi et al. [26]
results from a radical-mediated mechanism, which occurs prior to the modification by
glutathione. However, due to the larger size of glutathione compared to NO, it was
hypothesized that Ras glutathiolation at Cys118 causes structural changes in the nucleotide
binding pocket, leading to perturbation of guanine nucleotide binding and an increased rate
of nucleotide exchange [21]. As Cys118 is critical for the radical-mediated regulation of Ras
activity, we sought to circumvent the confounding factors of peroxynitrite and angiotensin II
use in cells by directly determining whether glutathiolation at Cys118 alters Ras structure
and activity in vitro.
While Ras has been shown to be glutathiolated in cells [21, 23, 26, 27], it is unclear how
glutathiolation alters Ras activity. Therefore, we employed NMR and fluorescence-based
biochemical assays to assess whether glutathione modification of Ras perturbs Ras structure
or activity. We find that treatment of Ras with oxidized glutathione leads to glutathiolation
specifically at Cys118, which does not alter Ras tertiary structure or guanine nucleotide
binding. These results are consistent with our previous observations that S-nitrosation of Ras
Cys118 does not perturb the structure or activity of Ras [19]. Therefore, our data suggests
that glutathiolation can only affect Ras activity if modification proceeds through a radical-
mediated reaction. Moreover, Ras glutathiolation prevents further redox-mediated activation
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of Ras by free radical-based mechanisms, which may serve to protect Ras from future
radical-mediated oxidation events under conditions of oxidative stress.
Materials and Methods
Ras purification and glutathiolation
Truncated human H-ras (H-Ras1-166) was cloned into the pQlinkH vector (Addgene;
Cambridge, MA), which contains an N-terminal 6x-His purification tag followed by a
Tobacco Etch Virus protease cleavage site for removal of the affinity tag. The hypervariable
region of Ras, including the C-terminal CAAX box, was removed as this region does not
undergo post-translational lipid modification in bacteria, is unstructured, and its removal
does not affect guanine nucleotide binding or GTP hydrolysis [34]. All proteins were
expressed in BL21 (DE3) RIPL cells (Stratagene; La Jolla, CA) and purified following the
Qiagen Nickel NTA purification protocol (Germantown, MD). Ras was further purified by
size exclusion chromatography (Superdex-75 10/300 GL column; GE Life Sciences;
Piscataway, NJ) and judged greater than 95% pure by SDS-PAGE analysis.
Ras was modified with glutathione by the addition of 1000× oxidized glutathione to purified
Ras in glutathiolation buffer (50 mM Tricine pH 8.0, 50 mM NaCl, 5 mM MgCl2, and 30
μM GDP) at 37°C for 15 min. Prior the addition of glutathione, Ras was reduced with
dithiothreitol (DTT) for 30 min at pH 8.5 before being buffer exchanged into glutathiolation
buffer that was flushed with N2 gas to remove dissolved oxygen and prevent auto-oxidation.
Mass Spectrometry of glutathiolated-Ras and Ras
Ras mass measurements were performed on an LTQ-Orbitrap Velos mass spectrometer
(Thermo Scientific; San Jose, CA). The mass analysis of intact Ras samples was achieved in
full-mass spectrometry (MS), selected-ion monitoring (SIM), and higher energy collisional
dissociation-(HCD)-MS/MS modes with a resolution of 120,000 at m/z 400 Da. The intact
MS spectra were deconvoluted using ProMass, and HCD-MS/MS product ion spectra were
processed manually by assigning sequence ions to theoretical masses corresponding to
RasSSG. The bottom-up peptide identification of trypsinized Ras samples was performed
using reversed phase LC-MS/MS on a nano-LC ultra 2D plus (Eksigent Inc; Dublin, CA)
coupled to an LTQ-Orbitrap Velos as described previously [35]. Briefly, data acquisition
included a full-MS scan on the Orbitrap (externally calibrated to a mass accuracy of < 1 ppm
and instrumental resolving power of 60,000 at m/z 400 Da) followed by intensity-dependent
CAD-MS/MS of the top 10 most abundant peptide ions. Mass spectra were processed, and
peptide identification was performed using Mascot (Matrix Science Inc.) against a Human
Uniprot database. Peptides were confidently identified using a target-decoy approach with a
false-discovery-rate (FDR) of 1%. A precursor ion mass tolerance of 200 ppm and product
ion mass tolerance 0.5 Da with a maximum of two missed cleavages and variable
modifications of cysteine glutathiolation and oxidation were used as a protein database
search parameter. All peptides were filtered and reported within a mass accuracy of 5 ppm.
Nucleotide exchange and hydrolysis assays
The rate of GDP dissociation from Ras was measured using 2′-/3′-O-(N’-
Methylanthraniloyl)guanosine-5′-O-diphosphate (MANTGDP) as previously reported [36,
37]. One micromolar Ras (RasWT, RasSSG, or RasC118S) loaded with MANTGDP (BioLog;
San Diego, CA) was added to 1 mL of degassed assay buffer (50 mM Tris pH 7.4, 50 mM
NaCl, 5 mM MgCl2, 2 mM GDP, and 100 μM diethylenetriaminepentaacetic dianhydride;
DTPA), and the rate of guanine nucleotide dissociation was measured by monitoring the
change in fluorescence (excitation: 365 nm; emission: 435 nm; 25°C) over time using a
Perkin Elmer LS50B fluorimeter (Waltham, MA). All experiments were performed in
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triplicate. Fluorescent nucleotide dissociation curves were fit to a one-phase exponential
decay equation using GraphPad Prism version 3.03 (GraphPad Software; San Diego, CA).
For GEF-induced Ras-GDP dissociation assays, the minimal catalytic domain of Son of
Sevenless (SOScat) was used at a 1:1 ratio to Ras. This concentration of SOScat was selected
as the rate enhancement of nucleotide exchange was easy to measure using fluorimetric
assays and other labs have published using the GEF at this concentration. The SOScat
construct (from John Kuriyan; University of California, Berkeley) was expressed and
purified as previously described [38].
Rates of GTP hydrolysis were determined using a Spectramax M5 (Molecular Devices;
Sunnyvale, CA) fluorimeter by monitoring phosphate production upon GTP hydrolysis [39].
FLIPPi 5U (Addgene; Cambridge, MA) was used as the phosphate sensor, and the minimal
catalytic domain of p120GAP [40] was added to stimulate the rate of Ras GTP hydrolysis.
The expression, purification, and use of this sensor have been previously reported [41].
Briefly, all assays used 10 μM FLIPPi with 10 μM GTP-loaded Ras. GTP loading was
performed as previously described [39]. Trace phosphate was removed from all buffers
using a ‘phosphate mop’ [42]. The rate of GTP hydrolysis was measured by taking the ratio
of the 535- and 485-nm emission wavelengths (excitation: 435 nm; 25°C) of kinetic runs
performed in triplicate and fit to a one-phase exponential association curve. For these
experiments, the ratio of GAP to Ras was 1:200, and the minimal catalytic domain of p120
RasGAP was used.
Nitric oxide-induced nucleotide dissociation
To determine whether addition of nitric oxide to RasWT, RasSSG, and RasC118S alters the
rates of GDP dissociation, we used the NO• donor DEANO (diethylammonium (Z)-1-(N,N-
diethylamino)diazen-1-ium-1,2-diolate; Alexis Chemicals; Farmingdale, NY). Previous
studies have shown that NO• in the presence of O2 forms •NO2, which promotes nucleotide
dissociation in Ras [14]. Therefore, all buffers used with DEANO were not degassed and
were vigorously shaken prior to use. To verify the time-dependent formation of NO• by
DEANO in our buffers, diaminofluorescein (DAF; Sigma) was used (data not shown). DAF
displays an increased fluorescence upon exposure to NO• radicals with an excitation
wavelength of 445 nm and an emission wavelength of 515 nm. All runs were performed in
triplicate with 1 μM MANT-loaded Ras in assay buffer. DEANO was added at the indicated
concentrations at the start of each run. Fluorescent nucleotide dissociation curves were fit
using one-phase exponential decay using GraphPad Prism as described above.
NMR analysis
NMR experiments were collected on a Varian Inova 700 MHz spectrometer at 25°C. The
2D 1H–15N heteronuclear single quantum coherence spectroscopy (HSQC) experiments
were performed with pulsed field gradient and water flip-back methods as previously
described [43]. Uniformly labeled 15N-enriched Ras was purified as previously described
[44]. 2D 1H-15N HSQC experiments were acquired on 0.8 mM 15N-enriched RasWT and
RasSSG with 1,024 × 128 complex data points and a spectral width of 8,000 Hz for the 1H
dimension and 1,709 Hz for the 15N dimension. Buffer contained 10 mM maleate (pH 6.5),
5 mM MgCl2, 40 mM NaCl, 20 μM GDP, and 10% D2O. NMR data were processed and
analyzed using NMR PIPE [45] and NMR ViewJ (One Moon Scientific; Newark, NJ).
Results
Modification of RasC118 by glutathione
As RasC118 has been previously identified as the site of oxidative modification by nitric
oxide [19], we used a combination of top-down and bottom-up MS to confirm that Cys118 is
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the preferred site of glutathiolation. Whereas partial modification of Ras by glutathione was
obtained at a ratio of 50:1 GSSG to Ras upon incubation for 15 min at pH 8.5 (Fig. 1a),
increasing the GSSG to Ras ratio to 1000:1 resulted in conversion of hRas1-166 to a
predominantly single glutathiolated form. However, Ras glutathiolation was not observed
when the redox insensitive RasC118S variant was treated under the same conditions (Fig. 1b).
All full-MS and selected-ion monitoring (SIM) scans corresponding to glutathiolated
RasC118 and redox-insensitive RasC118S are available in supporting data (Fig. S1). We have
also confirmed the site-specificity of hRas1-166 glutathiolation using top-down HCD-MS/
MS of the 13+ charge state (Fig. S2) and bottom-up identification of surrogate triply charged
tryptic peptides that constitute Cys118 (Fig 1c-d). The top-down data contain diagnostic
neutral loss ions corresponding to Cys-glutathionyl and glutathione as well as backbone
product ions, which suggests that the glutathione moiety is present exclusively on Cys118. In
concordance with hRas1-166, bottom-up peptide mass spectra show diagnostic neutral loss of
Cys-glutathionyl and sequence ions that unambiguously localize glutathione on Cys118. Our
mass spectrometry data indicate that RasC118, which is solvent exposed in the structure of
hRas1-166 (pdb: 1crp), is susceptible to glutathiolation, whereas the two solvent inaccessible
cysteine residues (Cys51 and Cys80) were unmodified under the tested conditions.
Glutathiolation of RasC118 does not significantly affect Ras-GDP nucleotide dissociation or
GTP hydrolysis
It has previously been observed that peroxynitrite addition to BAECs and VSMCs promotes
the formation of glutathiolated Ras at Cys118. Moreover, glutathiolation was concluded to be
an activating modification as the population of activated Ras was also glutathiolated [21, 22,
26]. As exposure of Ras to peroxynitrite in cells could generate RasC118• and RasSSG, it is
difficult to distinguish which modification, the thiyl radical or glutathione, leads to Ras
activity changes under the experimental conditions used. To assess whether glutathiolation
alters Ras guanine nucleotide binding and/or GTP hydrolysis, we performed nucleotide
dissociation and GTP hydrolysis assays on unmodified and glutathiolated hRas1-166 in vitro.
As shown in Fig. 2a and b, the intrinsic rates of GDP dissociation (kobs) for RasWT and
RasSSG (Fig. 2a-b) were determined to be similar (3.9 ± 0.1×10−5 s−1 vs. 4.7 ± 0.5×10−5
s−1). As the intrinsic rate of nucleotide dissociation for Ras is slow, interactions with GEFs
are required to facilitate nucleotide exchange in vivo. Therefore, we measured the rate of
GDP dissociation in the presence of SOS, a Ras GEF, as previously described [36]. When
the minimal catalytic domain of SOS (SOScat) was added to Ras, the rate of nucleotide
dissociation for RasSSG and RasWT was similar (18.5 ± 0.5×10−4 s−1 vs. 20.2 ± 0.7×10−4
s−1, respectively).
To determine the effect of glutathiolation on Ras-GTP hydrolysis rates, we measured the
rate of GTP hydrolysis in the presence and absence of the minimal catalytic domain of the
Ras-specific GAP, p120GAP [40]. For this assay, the phosphate binding protein FLIPPi 5U
was employed as a phosphate sensor. FLIPPi binds to free phosphate in solution and has a
measurable change in fluorescence upon phosphate binding [41]. By performing single-
turnover hydrolysis assays, the intrinsic rate of GTP hydrolysis for RasWT was determined
to be 0.6 ± 0.04×10−4 s−1 at 25°C (Fig. 2c-d), similar to previously reported values of
4.4×10−4 s−1, which were performed at a higher temperature of 30°C [46]. The rates of GTP
hydrolysis determined using the FLIPPi sensor compared to previously reported values,
indicating that this method is suitable for comparing GTP hydrolysis rates. The intrinsic rate
of GTP hydrolysis for RasSSG was determined to be ~4-fold slower (0.14 ± 0.06×10−4 s−1)
than for RasWT. However, as the intrinsic rate of GTP hydrolysis is too slow to be
biologically relevant and requires catalysis by GAPs in vivo to regulate Ras activity, we
measured the rate of hydrolysis in the presence of catalytic amounts of p120GAP. The rate of
GAP-mediated GTP hydrolysis for RasWT and RasSSG were observed to be similar (20.6 ±
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2.3×10−4 s−1 and 19.4 ± 1.7×10−4 s−1, respectively; Fig. 2c-d). Thus, glutathiolation of
RasC118 does not affect p120GAP-mediated GTP hydrolysis.
Glutathiolation at Cys118 does not perturb Ras structure
As it was previously suggested that Ras glutathiolation alters the structure of Ras and leads
to increased nucleotide exchange [21], we glutathiolated 15N-enriched hRas1-166 and
performed 2D NMR HSQC analyses. A 2D 1H-15N NMR HSQC allows for observation of
backbone and side chain N-H groups and provides a site-specific probe for every residue in
a protein aside from proline. An overlay of the RasWT and RasSSG HSQC spectra is shown
in Fig. 3a. Consistent with our MS data that Cys118 is the site of glutathiolation, the amide
resonance corresponding to Cys118 is perturbed upon Ras glutathiolation, whereas the
chemical shifts associated with Cys51 and Cys80 are unaltered. Glutathione is a tripeptide
(Gly-Cys-Glu), and modification of Ras at Cys118 is likely to alter the chemical environment
(chemical shift) of resonances proximal to the site of modification. As shown in Fig. 3a,
most resonances are unperturbed by glutathiolation of Ras at Cys118. By mapping the
residues that show chemical shift perturbations (14 peaks with chemical shift differences
greater than one linewidth, 0.05 ppm in the 1H dimension or 0.4 ppm in the 15N dimension)
onto the surface of the Ras structure (Fig. 3b), only residues proximal to the modified
cysteine show chemical shift changes. Interestingly, the chemical shift perturbations for
RasSSG (green in Fig. 3B) compared to RasSNO (orange; overlap is shown in purple, Cys118
in yellow) are similar, and we have previously shown that RasSNO does not alter Ras
structure [19]. Thus, the limited chemical shift changes close to the site of glutathiolation
and similarity between the HSQC spectra of RasWT, RasSSG, and RasSNO suggest minimal
structural perturbation by glutathiolation, consistent with our findings that the biochemical
properties of Ras are unaltered. Furthermore, the residues important for Ras recognition by
regulatory factors and effectors, including the p-loop (residues 10-17), Switch I, and Switch
II, do not show chemical shift changes upon glutathiolation. These data are consistent with
our findings that GEF- and GAP-mediated stimulation of GDP dissociation and GTP
hydrolysis were unaffected by Ras glutathiolation.
Glutathiolation impedes redox-mediated nucleotide dissociation
Previous studies have shown that treatment of Ras with •NO2 enhances the rate of nucleotide
dissociation, whereas nitrosation of Ras at this site prevents radical-mediated nucleotide
dissociation [15]. To determine whether Ras glutathiolation, like nitrosation, impedes free
radical-mediated dissociation in Ras, the rate of nucleotide dissociation was determined
using a MANTGDP-dissociation assay in the presence of the NO•-releasing agent DEANO
[47]. As shown in Fig. 4a, we observe an enhanced rate of RasWT-GDP dissociation in the
presence of DEANO (greater than 200-fold faster). In contrast, the rate of GDP dissociation
for the redox inactive RasC118S variant was insensitive to the presence of DEANO.
Furthermore, RasSSG was resistant towards DEANO-mediated nucleotide dissociation.
Although 1 mM DEANO was used in these experiments, only a small fraction
generates •NO2. DEANO releases NO• with a half-life of 15 minutes at pH 7.0, and NO•,
once generated, reacts with O2 to generate •NO2 [48, 49]. Moreover, the estimated dissolved
oxygen content in aqueous solution is only 250 M, which limits the amount of •NO2 that can
be formed. Thus, our results show that glutathiolation impedes free radical-dependent Ras
GDP dissociation, whereas glutathiolation does not significantly affect Ras structure,
activity, or interactions with modulatory proteins.
Discussion
A number of studies have reported Ras activity modulation by ROS and RNS [13]. Most of
these studies point to RasC118 as the redox-sensitive site because this cysteine has been
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shown to be oxidized by a number of cysteine-modifying agents and is required for redox-
mediated regulation of Ras activity [12]. Two of the most common oxidative modifications
identified for Ras in vivo are nitrosation and glutathiolation. We have previously reported
that radical-mediated nitrosation of Ras leads to increased guanine nucleotide dissociation
[50], whereas non-radical-mediated nitrosation of RasC118 does not affect Ras guanine
nucleotide binding [19]. Given these observations, we were intrigued by reports that
glutathiolation of Ras alters Ras activity [21, 22, 26, 27].
To better understand how Ras activity is modulated by glutathione, we considered radical-
and non-radical-mediated reactions that can result in Ras glutathiolation. Three potential
pathways of glutathiolation are presented in Fig. 6 (radical-mediated, 6a; and non-radical-
mediated, 6b and 6c). Earlier reports have suggested that glutathiolation leads to Ras
activation. For example, the fraction of activated GTP-bound Ras was higher in the pool
shown to be glutathiolated upon peroxynitrite exposure to BAECs [21] and after
administration of angiotensin II to VSMCs [26]. However, angiotensin II and peroxynitrite
produce free radicals. Angiotensin II produces ROS through NAD(P)H oxidase activation
[31, 51], and peroxynitrite can undergo homolysis to generate ROS and RNS. In fact, under
most physiological conditions, CO2 reacts with peroxynitrite to generate CO •−3 and •NO2
byproducts in fairly high yields (>30%) [52, 53]; in addition, under acidic conditions,
peroxynitrite can undergo proton catalyzed homolysis to form •OH and •NO2 [54]. An
important consideration that must guide in vitro experimentation with peroxynitrite is that in
the absence of CO2, peroxynitrite reacts directly with many biochemical targets, particularly
thiols. This oxidative reaction produces predominately non-radical oxidative products and is
faster than its homolysis to •OH and •NO2. Therefore, peroxynitrite reactions are heavily
context dependent. Importantly, given the high glutathione concentration in cells, once
peroxynitrite is decomposed and the free radical chain reactions are completed,
glutathiolated Ras will predictably be a major end product that is indistinguishable by all
means from the end product produced directly by the reaction of oxidized glutathione with
RasWT. Therefore, we postulate that the exogenous addition of peroxynitrite and angiotensin
II promotes Ras thiyl radical-mediated oxidation of the bound guanine nucleotide, leading to
Ras activation. Further, the resulting thiyl radical can react with glutathione to produce
RasSSG•, which aerobically decays to RasSSG and O •−2. This route of activation is shown in
Fig. 6A, and based on our analysis, is the likely pathway of glutathiolation that would result
in Ras activation in vivo. Interestingly, Ras glutathiolation appears to protect Ras from
further free radical-mediated events. We evaluated guanine nucleotide binding of RasWT,
RasC118S, and RasSSG in the presence of the NO-releasing agent DEANO. In these
experiments (Fig. 4), glutathiolated Ras was protected from free radical-mediated nucleotide
dissociation. Therefore, glutathione, which likely modifies Ras after an initial activating
event, could protect Ras from over-oxidation in cells under conditions of oxidative stress.
The other potential pathways of Ras glutathiolation shown in Figure 6 are unlikely to lead to
Ras activation (Fig. 6b and 6c). To demonstrate this, we generated glutathione-modified Ras
through a non-radical-mediated pathway by treating Ras with oxidized glutathione (Fig. 6b),
which glutathiolates Ras at Cys118, and find that neither the intrinsic or regulator (GEF/
GAP)-mediated rates of guanine nucleotide dissociation and hydrolysis are altered (Fig. 2).
However, as the cellular concentration of oxidized glutathione is generally quite low
(GSH:GSSG ratio in cells is >100:1) [55] and the reaction rate slow, this is an unlikely
pathway of Ras glutathiolation in cells. To experimentally validate the role of glutathione on
nucleotide exchange, we exposed RasWT and RasC118S to oxidized glutathione (similar to
the pathway presented in Fig. 6b) and found that Ras guanine nucleotide binding was not
affected by the presence of oxidized glutathione (Fig. 5). While this data appears
contradictory to the results described by Clavreul et al. [21], identical levels of Ras
nucleotide dissociation were observed, which was approximately 5% of the bound
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nucleotide after 300 s. In our experiments, we also tested RasC118S and observed identical
levels of nucleotide dissociation, indicating that glutathione does not promote guanine
nucleotide release from Ras. We also present GEF-induced dissociation of RasWT and
RasC118S within Fig. 5 to highlight the difference in GSSG-mediated dissociation and GEF-
mediated dissociation. Furthermore, as the experimental conditions used in Clavreul et al.
[21] were not conducive to peroxynitrite-mediated radical formation [7], glutathiolation is
unlikely to result in Ras activation. Thus, results from this study do not support Ras activity
modulation due to the presence of the glutathione moiety on Ras.
Seemingly in direct contradiction with our results, Adachi et al. observed that
overexpression of glutaredoxin-1 (GRX-1) in VSMCs inhibited Ras glutathiolation and
activation upon stimulation with peroxynitrite [26]. However, overexpressed redox proteins
can have profound effects on the cellular oxidation state, and it has been previously shown
that downregulation of GRX-1 can sensitize lens epithelial cells to oxidative stress-induced
apoptosis [56]. Moreover, overexpression of GRX-1 protects against doxorubicin-induced
cell death [57, 58], which mediates cell death through increased oxidative stress [59].
Therefore, overexpression of GRX-1, as in Adachi et al., likely decreased the level of
oxidative stress, which would result in reduced Ras activation by radical-mediated
oxidation.
Another possible reaction pathway to consider is shown in Figure 6c. As disulfide bond
formation generally proceeds through a sulfenic acid intermediate, it is possible that
oxidation of Cys118 to a sulfenic acid will lead to RasSSG formation in the presence of
reduced glutathione, which is present at a high levels in cells (GSH:GSSG ratio in cells is
>100:1). As this pathway does not generate radical intermediates, we postulate that it is
unlikely to alter Ras activity. While the products of angiotensin II or peroxynitrite exposure
to cells can lead to Ras glutathiolation by the pathway presented in Fig. 6c; the relative rate
of oxidation is likely too slow to be physiologically relevant. It is more likely that
glutathiolation occurs through radical-mediated interactions in cells. However, as Ras
glutathiolation can proceed through pathways that do not alter Ras activity, it is difficult to
use Ras glutathiolation as a marker of Ras activity regulation unless Ras radical formation
can be detected coincident with Ras glutathiolation.
Conclusions
We have previously shown that •NO2 can increase the rate of nucleotide dissociation in Ras
and that modification of Ras by NO• renders Ras less sensitive to radical-mediated oxidation
[19]. Consistent with these observations, RasSSG does not affect the structure or activity of
Ras. When considering the faster reaction rates of radical vs. non-radical-mediated cysteine
oxidation, we postulate that activation mediated through oxidation of Ras in vivo occurs
through the formation of a Ras thiyl-radical intermediate (Fig. 6). The Ras thiyl radical can
promote Ras activation under appropriate redox conditions by facilitating nucleotide
exchange and can react with NO• or GS• radicals to form RasSNO or RasSSG (Fig. 6). While
these end products do not alter Ras guanine nucleotide binding or hydrolysis, they impede
Cys118 from engaging in further free radical-mediated reactions (Fig. 4). Therefore, we
postulate that coincident detection of Ras glutathiolation and activation results from Cys118
thiyl radical-mediated oxidation of the guanine base and GDP release.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Ras is selectively modified by glutathione at cysteine 118
• Ras structure is unaffected by glutathione modification at cysteine 118
• Ras glutathiolation is non-activating unless it proceeds through a free radical
• Nucleotide exchange and hydrolysis of glutathiolated Ras are similar to RasWT
• Free radical-induced modifications at cysteine 118 activate Ras
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(a) Intact deconvoluted mass spectrum resulting from the reaction of RasWT with GSSG.
The major peaks correspond to unmodified and singly glutathiolated Ras. (b) Intact
deconvoluted MS resulting from the reaction of RASC118S with GSSG. The peak
corresponds to unmodified RASC118S. Note: The deconvoluted mass spectra in Fig 1 a-b
also consist of gas-phase sodium adducts of Ras. (c) MS/MS-CID spectrum of a triply
charged RASWT peptide glutathiolated at Cys118. The glutathione modification is localized
at Cys118, and the diagnostic neutral loss of 129 Da corresponds to glutathionyl-cysteine
[60]. (d) MS/MS-CID spectrum of the unmodified triply charged peptide counterpart.
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Biochemical characterization of glutathione-modified Ras. (A) Rates of GDP dissociation
were determined for RasWT, RasC118S, and RasSSG (1 μM). Nucleotide dissociation kinetic
traces in the absence (open symbols) and presence (closed) of the GEF SOScat are shown.
(B) The relative rates of GDP dissociation (kobs) are presented. (C) Representative Ras GTP
hydrolysis kinetic traces in the absence (open symbols) and presence (closed) of
p120RasGAPcat. (D) The relative rates of hydrolysis in the absence and presence of GAP are
presented. All reactions were performed in triplicate and were fit to a single exponential
dissociation/association curve using GraphPad Prism, and the error is reported as the
standard deviation of the replicates. Normalized results are presented for graphical
comparison of the experiments. The experimental conditions and data analysis for these
assays are described in the Materials and Methods.
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2D NMR 1H-15N HSQC comparison of RasWT and RasSSG. (A) A 1H-15N 2D HSQC
overlay of RasWT (black) with RasSSG (red). The black-labeled residues indicate Ras NH
resonances associated with residues that shift upon glutathione modification (peak shifts
greater than 1 linewidth, 0.05 ppm in the 1H dimension or 0.4 ppm in the 15N dimension),
and the blue-labeled residues correspond to the other two cysteines in Ras (Cys51 and
Cys80), which do not show amide peak shifts between RasWT and RasSSG. (B) Residues
corresponding to the NH resonances that show chemical shift changes for RasSSG but not
RasNO are highlighted in green on a surface representation of hRas1-166, while residues that
show chemical shift changes in RasSNO are highlighted in orange. The residues that showed
chemical shifts in both RasSSG and RasSNO are highlighted in purple. Cys118, the site of
modification, is shown in yellow, GDP is shown as sticks, magnesium is shown as a red
sphere, and Switch I (blue), Switch II (teal), and the p-loop (pale blue) are shown for clarity.
Surface rendering was generated with PyMol using pdb: 1crp.
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MANTGDP nucleotide dissociation assays in the presence of the NO-generating agent
DEANO. (A) RasWT was pre-loaded with MANTGDP and exposed to increasing
concentrations of DEANO in the absence of unlabeled GDP. All conditions contained 1 μM
RasWT and ◆ 250 μM DEANO, ▾ 500 μM DEANO, or ◆ 1 mM DEANO added at the start
of the experiment. (B) ◆ RasWT, * RasC118S, and 엯 RasSSG (1 μM) were preloaded
with MANTGDP and exposed to 1 mM DEANO. All reactions were performed in triplicate
and were fit to a single exponential dissociation curve using GraphPad Prism. Normalized
results are presented for graphical comparison of the experiments.
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MANTGDP dissociation measured for RasWT (◆) and RasC118S (▴) in the presence of 100
μM GSSG (closed symbols) and in the presence of SOScat (open symbols). MANTGDP
nucleotide dissociation was performed as described in Fig. 2; however, no unlabeled GDP
was present and 100 μM oxidized glutathione was added to the reaction cuvette. All
reactions were performed in triplicate and were fit to a single exponential dissociation curve
using GraphPad Prism. Error bars have been removed for clarity. Ras and RasC118S with 1
μM GEF are shown for comparison. Normalized results are presented for graphical
comparison of the experiments.
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Modification of Ras by glutathione can proceed by three different mechanisms. In pathway
A, redox agents capable to generating a Ras thiyl radical can induce radical formation on
RasC118; electron transfer results in guanine-radical formation, guanine-base oxidation, and
release of the oxidized base from Ras. Given the ratio of GTP/GDP in cells (~30:1), release
of GDP promotes GTP binding. Free radical-induced oxidation leaves Ras in the thiyl anion
form, which is more reactive to oxidation and can result in glutathione modification. In
pathway B, Ras can react with oxidized glutathione through disulfide exchange to form
glutathiolated Ras. Given the slow rate of this reaction and concentration of GSSG in cells,
this pathway is unlikely to have a large contribution to Ras glutathiolation in vivo. In
pathway C, Ras is oxidized by a non-radical oxidant, such as H2O2, which results in sulfenic
acid formation at RasC118. Sulfenic acids are an intermediate step in disulfide bond
formation; therefore, this form of Ras can interact with reduced glutathione to form
glutathiolated Ras. However, RasSSG formed by non-radical means does not affect guanine
nucleotide binding, nucleotide hydrolysis, or Ras activation. Thus, Ras activation and
glutathiolation likely occurs in cells by reaction of Ras with thiyl radical-generating agents
(pathway A), which promotes activation through nucleotide dissociation and GTP binding.
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